G. Ferguson

Pulmonary Research Institute of Southeast Michigan

Poster Author Of 3 e-Posters

 ePosters
09. COPD, Emphysema, Chronic Bronchitis, Alpha-1 Antitrypsin Deficiency

A1588 - Benefits of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) in Reducing Exacerbation Risk in Patients with Moderate-to-Very Severe COPD: A Pooled Analysis of the PINNACLE Studies

Presenter:
Date
05/19/2019
Room
Area B (Hall F, Level 2), KBHCCD
Session Name
A41 - COPD: EPIDEMIOLOGY
Session Type
Thematic Poster Session
Authors
09. COPD, Emphysema, Chronic Bronchitis, Alpha-1 Antitrypsin Deficiency

A3351 - 12-Hour Lung Function Assessment of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Delivered by Co-Suspension Delivery Technology in Patients with COPD

Presenter:
Date
05/20/2019
Room
Area D (Hall F, Level 2), KBHCCD
Session Name
B45 - COPD: TREATMENT
Session Type
Thematic Poster Session
Authors
09. COPD, Emphysema, Chronic Bronchitis, Alpha-1 Antitrypsin Deficiency

A7098 - Efficacy of Tiotropium/Olodaterol Compared with Tiotropium in Patients Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials

Presenter:
Date
05/22/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
D101 - CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD
Session Type
RAPiD: Rapid Abstract Poster Discussion Session
Authors